- In January 2022, to deliver non-invasive prenatal testing (NIPT) solutions to QIAGEN's dPCR business, QIAGEN formed partnerships with Atila BioSystems
- In June 2021, Next-generation genomics and Illumina Thailand has launched the VeriSeq NIPT Solution v2, a next-generation sequencing (NGS)-based solution that helps detect anomalies missed by targeted tests
